Organometallics
Article
3-Bromo-2-((5-nitropyrimidin-2-yl)amino) Phenylacetate
(2j). According to the representative reaction procedure (I): Light
yellow solid (0.229 g, 0.65 mmol, 65% yield); Rf = 0.51, (PE/EtOAc
= 5/1(v/v)). NMR spectroscopy: 1H NMR (300 MHz, CDCl3,25 °C,
δ): 9.31 (s, 2 H), 7.73 (d, J = 7.8 Hz, 1 H), 7.46 (t, J = 7.5 Hz, 1 H),
7.38−7.26 (m, 2 H), 2.62 (s, 3 H). 13C NMR (75 MHz, CDCl3, 25
°C, δ): 171.9, 162.3, 154.2, 139.5, 138.1, 133.8, 130.6, 130.3, 128.9,
123.7, 26.9. Mass spectrometry: HRMS (ESI-TOF) (m/z): calcd for
Reddish brown solid (0.205 g, 0.51 mmol, 51% yield); Rf = 0.24 (PE/
EtOAc = 2/1(v/v)). 1H NMR (300 MHz, CDCl3, 25 °C, δ): 9.15 (s,
2 H), 7.90 (s, 1H), 7.83 (s, 1 H), 7.55 (d, J = 8.4 Hz, 1H), 7.36 (s, 1
H), 7.32−7.30 (m, 3 H), 7.17 (d, J = 7.1 Hz, 1H), 7.12 (d, J = 8.6 Hz,
1 H), 5.28 (s, 2 H), 2.36 (s, 3 H). 13C NMR (75 MHz, CDCl3, 25 °C,
δ): 168.6, 161.3, 155.2, 137.0, 135.4, 133.4, 132.5, 130.0, 129.0, 128.0,
127.1, 118.5, 118.2, 114.6, 102.8, 50.5, 21.1. HRMS (ESI-TOF) (m/
+
z): calcd for C21H18N5O4 ([M + H]+), 404.1353, found, 404.1358.
+
C12H10BrN4O4 ([M + H]+), 352.9880; found, 352.9876.
5-((5-Nitropyrimidin-2-yl)amino) Benzo [b] thiophen-4-yl
Acetate (2t). According to the representative reaction procedure (I):
Light yellow solid (0.204 g, 0.62 mmol, 62% yield); Rf = 0.47 (PE/
EtOAc = 2/1(v/v)). 1H NMR (300 MHz, CDCl3, 25 °C,δ): 9.18 (s, 2
H), 7.93 (d, J = 8.7 Hz, 1 H), 7.82 (d, J = 8.6 Hz, 1 H), 7.80 (s, 1 H),
7.52 (d, J = 5.5 Hz, 1 H), 7.23 (d, J = 5.5 Hz, 1 H), 2.45 (s, 3 H). 13C
NMR (101 MHz, CDCl3, 25 °C,δ): 168.6, 162.0, 155.4, 139.1, 138.0,
133.8, 128.8, 125.6, 121.9, 120.8, 120.0, 21.0. HRMS (ESI-TOF) (m/
z): calcd for C14H11N4O4S+ ([M + H]+), 331.0496, found, 331.0494.
Procedure for Synthesis of 2-Amino-5-chlorophenol (2f′).
Under N2 atmosphere, an oven-dried 25 mL flask was charged with
the 5-chloro-2-((5-nitropyrimidin-2-yl)amino) phenylacetate (0.154
g, 0.5 mmol, 1.0 equiv) in THF (2.50 mL, 0.20 M). Hydrazine
monohydrate (0.05 g, 1.0 mmol, 2.0 equiv) was added dropwise, and
the reaction was stirred for 30 min at 25 °C. The reaction mixture was
monitored via TLC until the disappearance of starting material (Rf =
0.20 (PE/EtOAc = 5/1 (v/v)). The reaction was quenched by water
and extracted with ethyl acetate (10 mL ⊆ 3). The combined organic
layer was washed with brine, dried over anhydrous MgSO4, and
concentrated under reduced pressure. The residue was purified by
column chromatography on silica gel (PE/EtOAc = 5:1 to 2:1 as an
eluent) to give 2f′ as dark brown solid (0.082 g, 0.44 mmol, 88%
2,4-difluoro-6-((5-nitropyrimidin-2-yl)amino) Phenylace-
tate (2k). According to the representative reaction procedure (I):
Light yellow solid (0.189 g, 0.61 mmol, 61% yield); Rf = 0.54 (PE/
EtOAc = 5/1(v/v)). NMR spectroscopy: 1H NMR (300 MHz,
CDCl3,25 °C, δ): 9.25 (s, 2 H), 8.16 (dt, J = 2.4 Hz, 10.7 Hz, 1 H),
7.82 (s, 1 H), 6.77−6.69 (m, 1 H), 2.44 (s, 3 H). 13C NMR (75 MHz,
CDCl3, 25 °C, δ): 167.5, 160.7, 158.4 (t, J = 6.0 Hz), 156.0 (t, J =
15.0 Hz), 155.0, 136.8, 132.3 (tt, J = 4.5 Hz, 14.3 Hz), 125.1 (t, J = 21
Hz), 104.1 (tt, J = 3.8 Hz, 29.3 Hz), 100.3 (tt, J = 2.3 Hz, 27.8 Hz),
20.4. Mass spectrometry: HRMS (ESI-TOF) (m/z): calcd for
+
C12H9F2N4O4 ([M + H]+), 311.0586; found, 311.0574. 19F NMR
(75 MHz, CDCl3, 25 °C,δ): −110.9, −122.8.
Methyl 3-acetoxy-4-((5-nitropyrimidin-2-yl)amino)-
benzoate (2l). According to the representative reaction procedure
(I): Light yellow solid (0.193 g, 0.58 mmol, 58% yield); Rf = 0.53
1
(PE/EtOAc = 2/1(v/v)). NMR spectroscopy: H NMR (300 MHz,
CDCl3,25 °C, δ): 9.19 (s, 1H), 7.95 (s, 1H), 7.63 (s, 1H), 7.11−7.04
(m, 2H), 2.40 (s, 3H) 2.34 (s, 3H). 13C NMR (75 MHz, CDCl3, 25
°C, δ): 168.8, 165.2, 161.2, 155.1, 142.2, 136.1, 134.8, 126.6, 126.0,
124.4, 124.3, 52.3, 21.2. Mass spectrometry: HRMS (ESI-TOF) (m/
+
z): calcd for C14H13N4O6 ([M + H]+), 333.0830; found, 333.0836.
1
2-((5-Nitropyrimidin-2-yl) amino)-5-(trifluoromethoxy) Phe-
nylacetate (2m). According to the representative reaction procedure
(I): Light yellow solid (0.191 g, 0.56 mmol, 56% yield); Rf = 0.35
yield); Rf = 0.28 (PE/EtOAc = 5/1(v/v)). NMR spectroscopy: H
NMR (300 MHz, CDCl3, 25 °C, δ): 6.78−6.72 (m, 2 H), 6.70−6.63
(m, 1 H). 13C NMR (75 MHz, CDCl3, 25 °C, δ): 145.3, 134.0, 122.1,
119.4, 115.7, 115.0. Compound 2f′ is known.76
1
(PE/EtOAc = 5/1(v/v)). H NMR (300 MHz, CDCl3, 25 °C, δ):
9.25 (s, 2 H), 8.57 (d, J = 8.6 Hz, 1 H), 7.85 (s, 1 H), 7.56 (d, J = 8.7
Hz, 1 H), 7.52 (s, 1 H), 2.43 (s, 3 H). 13C NMR (75 MHz, CDCl3, 25
°C,δ): 168.3, 160.9, 155.1, 140.3, 136.7, 132.8, 127.0, 126.5, 123.6 (J
= 15.1 Hz), 122.0, 120.0 (J = 15.6 Hz), 21.2. 19F NMR (75 MHz,
CDCl3, 25 °C,δ): −62.2. HRMS (ESI-TOF) (m/z): calcd for
2-Amino-5-bromophenol (2g′). The same procedure as
obtaining 2f′: Dark brown solid (0.0855 g, 0.45 mmol, 91% yield);
Rf= 0.31 (PE/EtOAc = 5/1(v/v)). NMR spectroscopy: 1H NMR
(300 MHz, (CD3)2SO, 25 °C, δ): 9.49 (brs, 1H), 6.77 (d, J = 2.2 Hz,
1H), 6.68 (dd, J = 8.3, 2.2 Hz, 1H), 6.53 (d, J = 8.3 Hz, 1H), 4.7 (brs,
2H). 13C NMR (75 MHz, (CD3)2SO, 25 °C,δ): 145.2, 136.4 121.9,
116.7, 115.4, 106.2. Compound 2g′ is known.77
+
C13H10F3N4O4 ([M + H]+), 343.0649, found, 343.0643.
1-(5-Nitropyrimidin-2-yl)-1, 2, 3, 4-tetrahydroquinolin-8-yl
Acetate (2p). According to the representative reaction procedure
(I): Reddish brown solid (0.216 g, 0.69 mmol, 69% yield); Rf = 0.52
(PE/EtOAc = 5/1(v/v)). 1H NMR (300 MHz, (CD3)2SO, 25 °C, δ):
9.15 (s, 2 H), 7.29−7.23 (t, J = 15.4 Hz, 1 H), 7.17 (d, J = 6.0 Hz,
1H), 7.09 (dd, J = 1.4 Hz, J = 7.9 Hz, 1 H), 2.75 (s, 2 H), 1.99 (s, 2
H), 1.86 (s, 3 H), 1.24 (m, 2 H) 13C NMR (75 MHz, CDCl3, 25 °C,
δ): 168.3, 161.3, 154.6, 144.8, 136.3, 135.2, 131.1, 126.9, 125.8, 121.0,
45.6, 26.3, 24.1, 21.1. HRMS (ESI-TOF) (m/z): calcd for
Gram-Scale Synthesis of Compound 2g. Under N2 atmos-
phere, an oven-dried 250 mL flask was charged with 4-bromoaniline
(1.03 g, 6.0 mmol, 1.0 equiv) and 2-chloro-5-nitropyrimidine (0.96 g,
6.0 mmol, 1.0 equiv) in CH3CN (9.0 mL, 1.50 M). The reaction
mixture was stirred for 4 h at room temperature, which was monitored
via TLC until the disappearance of 2-chloro-5-nitropyrimidine (Rf =
0.79, (PE/EtOAc = 5/1 (v/v)). AcOH (12.0 mL) and Ac2O (12.0
mL) were directly added to the reaction mixture, followed by
Pd(OAc)2 (67.2 mg, 0.3 mmol, 0.05 equiv) and PhI(OAc)2 (2.19 g,
6.6 mmol, 1.10 equiv). After stirring for 10 h at 100 °C, the reaction
mixture was concentrated under vacuo, purified by column
chromatography (eluent, PE/EtOAc = 25/1 to 5/1(v/v)) to give
the desired product as light yellow solid (1.12 g, 3.66 mmol, 61%
yield). Rf = 0.52 (PE/EtOAc = 5/1(v/v)).
One-Pot Procedure for Synthesis of Compound 2g′. Under
N2 atmosphere, an oven-dried 25 mL flask was charged with 4-
bromoaniline (0.172 g, 1.00 mmol, 1.00 equiv) and 2-chloro-5-
nitropyrimidine (0.159 g, 1.0 mmol, 1.00 equiv) in CH3CN (1.50 mL,
1.50 M). The reaction mixture was stirred for 4 h at room
temperature, which was monitored via TLC until the disappearance
of 2-chloro-5-nitropyrimidine (Rf = 0.79, (PE/EtOAc = 5/1 (v/v)).
AcOH (2.0 mL) and Ac2O (2.0 mL) were directly added to the
reaction mixture, followed by Pd(OAc)2 (5.60 mg, 0.05 mmol, 0.05
equiv) and PhI(OAc)2 (0.365 g, 1.10 mmol, 1.10 equiv). After it was
stirred for 6 h at 100 °C, the reaction mixture was concentrated under
vacuo, which was redissolved in THF (2.50 mL, 0.20 M). Hydrazine
monohydrate (101 mg, 2 mmol) was added dropwise. After stirring at
25 °C for 30 min. The reaction was concentrated under vacuo, diluted
with water (10 mL), extracted with ethyl acetate (10 mL ⊆ 3). The
+
C15H15N4O4 ([M + H]+), 315.1088, found, 315.1080.
2-(Methyl (5-nitropyrimidin-2-yl)amino) Phenylacetate
(2q). According to the representative reaction procedure (I): Yellow
brown solid (0.210 g, 0.73 mmol, 73% yield); Rf = 0.47 (PE/EtOAc =
1
5/1(v/v)). H NMR (300 MHz, CDCl3, 25 °C, δ): 9.19 (d, J = 3.1
Hz, 1 H), 9.00 (d, J = 3.18 Hz, 1 H), 7.45−7.34 (m, 3 H), 7.26−7.23
(m, 1 H), 3.53 (s, 3 H), 2.09 (s, 3 H). 13C NMR (75 MHz, CDCl3, 25
°C,δ): 168.7, 162.4, 154.9, 146.5, 136.0, 134.9, 129.2, 128.3, 127.3,
123.9, 39.0, 20.8. HRMS (ESI-TOF) (m/z): calcd for
+
C13H13N4O4 ([M + H]+), 289.0931, found, 289.0933
1-Benzyl-6-((5-nitropyrimidin-2-yl)amino)-1H-indol-5-yl Ac-
etate (2r). According to the representative reaction procedure (I):
Reddish brown solid (0.233 g, 0.58 mmol, 58% yield); Rf = 0.24 (PE/
EtOAc = 2/1(v/v)). 1H NMR (400 MHz, DMSO, 25 °C,δ): 10.84 (s,
1 H), 9.18 (s, 2 H), 8.01 (s, 1 H), 7.57 (s, 1 H), 7.41 (d, J = 8.5 Hz, 1
H), 7.35−7.31 (m, 3 H), 7.28−7.26 (m, 3 H), 5.34 (s, 2 H), 2.33 (s, 3
H). 13C NMR (101 MHz, DMSO, 25 °C,δ): 168.5, 161.0, 155.1,
137.8, 134.7, 133.3, 132.9, 128.8, 128.6, 127.5, 120.3, 118.4, 117.5,
117.2, 114.5, 102.8, 49.2, 20.7. HRMS (ESI-TOF) (m/z): calcd for
+
C21H18N5O4 ([M + H]+), 404.1353, found, 404.1363.
1-Benzyl-5-((5-nitropyrimidin-2-yl)amino)-1H-indol-6-yl Ac-
etate (2s). According to the representative reaction procedure (I):
E
Organometallics XXXX, XXX, XXX−XXX